Literature DB >> 20961593

The identification of HLA class II-restricted T cell epitopes to vaccinia virus membrane proteins.

Richard B Kennedy1, Gregory A Poland.   

Abstract

Three decades after the eradication of smallpox, the threat of bioterrorism and outbreaks of emerging diseases such as monkeypox have renewed interest in the development of safe and effective next-generation poxvirus vaccines and biodefense research. Current smallpox vaccines contain live virus and are contraindicated for a large percentage of the population. Safer, yet still effective inactivated and subunit vaccines are needed, and epitope identification is an essential step in the development of these subunit vaccines. In this study we focused on 4 vaccinia membrane proteins known to be targeted by humoral responses in vaccinees. In spite of the narrow focus of the study we identified 36T cell epitopes, and provide additional support for the physical linkage between T and B epitopes. This information may prove useful in peptide and protein-based subunit vaccine development as well as in the study of CD4 responses to poxviruses.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20961593      PMCID: PMC2975829          DOI: 10.1016/j.virol.2010.09.013

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  97 in total

Review 1.  B lymphocyte activation by contact-mediated interactions with T lymphocytes.

Authors:  G A Bishop; B S Hostager
Journal:  Curr Opin Immunol       Date:  2001-06       Impact factor: 7.486

2.  Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung.

Authors:  H D Chen; A E Fraire; I Joris; M A Brehm; R M Welsh; L K Selin
Journal:  Nat Immunol       Date:  2001-11       Impact factor: 25.606

3.  Cutting edge: long-term B cell memory in humans after smallpox vaccination.

Authors:  Shane Crotty; Phil Felgner; Huw Davies; John Glidewell; Luis Villarreal; Rafi Ahmed
Journal:  J Immunol       Date:  2003-11-15       Impact factor: 5.422

4.  Vaccinia virus-specific CD8(+) T-cell responses target a group of epitopes without a strong immunodominance hierarchy in humans.

Authors:  Masanori Terajima; Laura Orphin; Anita M Leporati; Pamela Pazoles; John Cruz; Alan L Rothman; Francis A Ennis
Journal:  Hum Immunol       Date:  2008-10-26       Impact factor: 2.850

5.  Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-gamma-producing T cells after smallpox vaccination.

Authors:  Francis A Ennis; John Cruz; Walter E Demkowicz; Alan L Rothman; David J McClain
Journal:  J Infect Dis       Date:  2002-05-17       Impact factor: 5.226

6.  A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies.

Authors:  E J Wolffe; S Vijaya; B Moss
Journal:  Virology       Date:  1995-08-01       Impact factor: 3.616

7.  Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses.

Authors:  James T Snyder; Igor M Belyakov; Amiran Dzutsev; François Lemonnier; Jay A Berzofsky
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

8.  Response to smallpox vaccine in persons immunized in the distant past.

Authors:  Sharon E Frey; Frances K Newman; Lihan Yan; Kathleen R Lottenbach; Robert B Belshe
Journal:  JAMA       Date:  2003-06-25       Impact factor: 56.272

9.  Quantitation of CD8+ T cell responses to newly identified HLA-A*0201-restricted T cell epitopes conserved among vaccinia and variola (smallpox) viruses.

Authors:  Masanori Terajima; John Cruz; Gregory Raines; Elizabeth D Kilpatrick; Jeffrey S Kennedy; Alan L Rothman; Francis A Ennis
Journal:  J Exp Med       Date:  2003-03-31       Impact factor: 14.307

10.  Monkeypox spreads as US public-health system plays catch-up.

Authors:  Marilynn Larkin
Journal:  Lancet Infect Dis       Date:  2003-08       Impact factor: 71.421

View more
  10 in total

1.  HLA alleles associated with the adaptive immune response to smallpox vaccine: a replication study.

Authors:  Inna G Ovsyannikova; V Shane Pankratz; Hannah M Salk; Richard B Kennedy; Gregory A Poland
Journal:  Hum Genet       Date:  2014-06-01       Impact factor: 4.132

2.  Identification of Novel Respiratory Syncytial Virus CD4+ and CD8+ T Cell Epitopes in C57BL/6 Mice.

Authors:  Megan E Schmidt; Steven M Varga
Journal:  Immunohorizons       Date:  2019-01-14

3.  Specificities of human CD4+ T cell responses to an inactivated flavivirus vaccine and infection: correlation with structure and epitope prediction.

Authors:  Julia Schwaiger; Judith H Aberle; Karin Stiasny; Bernhard Knapp; Wolfgang Schreiner; Ingrid Fae; Gottfried Fischer; Ondrej Scheinost; Vaclav Chmelik; Franz X Heinz
Journal:  J Virol       Date:  2014-04-30       Impact factor: 5.103

4.  CD4 T-cell memory responses to viral infections of humans show pronounced immunodominance independent of duration or viral persistence.

Authors:  Lichen Jing; Joshua T Schiffer; Tiana M Chong; Joseph J Bruckner; D Huw Davies; Phillip L Felgner; Juergen Haas; Anna Wald; G M G M Verjans; David M Koelle
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

5.  CD4+ T cells provide intermolecular help to generate robust antibody responses in vaccinia virus-vaccinated humans.

Authors:  Liusong Yin; J Mauricio Calvo-Calle; John Cruz; Frances K Newman; Sharon E Frey; Francis A Ennis; Lawrence J Stern
Journal:  J Immunol       Date:  2013-05-10       Impact factor: 5.422

6.  GM-CSF production allows the identification of immunoprevalent antigens recognized by human CD4+ T cells following smallpox vaccination.

Authors:  Valeria Judkowski; Alcinette Bunying; Feng Ge; Jon R Appel; Kingyee Law; Atima Sharma; Claudia Raja-Gabaglia; Patricia Norori; Radleigh G Santos; Marc A Giulianotti; Mark K Slifka; Daniel C Douek; Barney S Graham; Clemencia Pinilla
Journal:  PLoS One       Date:  2011-09-09       Impact factor: 3.240

7.  Better Epitope Discovery, Precision Immune Engineering, and Accelerated Vaccine Design Using Immunoinformatics Tools.

Authors:  Anne S De Groot; Leonard Moise; Frances Terry; Andres H Gutierrez; Pooja Hindocha; Guilhem Richard; Daniel Fredric Hoft; Ted M Ross; Amy R Noe; Yoshimasa Takahashi; Vinayaka Kotraiah; Sarah E Silk; Carolyn M Nielsen; Angela M Minassian; Rebecca Ashfield; Matt Ardito; Simon J Draper; William D Martin
Journal:  Front Immunol       Date:  2020-04-07       Impact factor: 7.561

Review 8.  Monkeypox: disease epidemiology, host immunity and clinical interventions.

Authors:  Fok-Moon Lum; Anthony Torres-Ruesta; Matthew Z Tay; Raymond T P Lin; David C Lye; Laurent Rénia; Lisa F P Ng
Journal:  Nat Rev Immunol       Date:  2022-09-05       Impact factor: 108.555

Review 9.  Personalized vaccinology: A review.

Authors:  G A Poland; I G Ovsyannikova; R B Kennedy
Journal:  Vaccine       Date:  2017-07-31       Impact factor: 4.169

Review 10.  Humanized Mice for Live-Attenuated Vaccine Research: From Unmet Potential to New Promises.

Authors:  Aoife K O'Connell; Florian Douam
Journal:  Vaccines (Basel)       Date:  2020-01-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.